On April 25, 2024, OncoCyte Corporation closed the transaction. The transaction included participation from 21 investors pursuant to Regulation D.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.965 USD | +2.24% | +2.14% | +14.80% |
04-25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.80% | 38.76M | |
+7.56% | 111B | |
+11.37% | 106B | |
-12.41% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.04% | 16.81B | |
+38.08% | 12.54B | |
-24.36% | 8.09B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation announced that it has received $15.807655 million in funding